A Phase 2 study of Decitabine-Carboplatin in recurrent, platinum-resistant ovarian cancer
Unknown Phase 2 NCT03467178
Study Description
A study evaluating the effectiveness and safety of the combination of Decitabine and Carboplatin compared to physician's choice chemotherapy in recurrent, platinum-resistant ovarian cancer
Study Details
- Registry ID:
- NCT03467178
- Conditions:
- Recurrent, Platinum-resistant Ovarian Cancer
- Phase:
- Phase 2
- Target Enrollment:
- 119 participants
- Start Date:
- Age Range:
- 18–999 years
- Gender:
- Female
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.